|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2006-12-21- -2006-12-27 Sale |
2006-12-27 5:19 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 5,365 | $2.889 | $15,500 | 1,300 (Direct) | View |
| 2006-12-19- -2006-12-20 Sale |
2006-12-20 8:55 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 6,000 | $3.005 | $18,030 | 6,665 (Direct) |
View |
| 2006-12-14- -2006-12-18 Sale |
2006-12-18 6:45 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 9,000 | $3.034 | $27,305 | 12,665 (Direct) |
View |
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship |
Shares Traded | Average Price |
Total Amount | Shares Ownership | Filing |
| 2005-12-14 Option Award | 2005-12-15 6:56 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 101,827 | $0 | $0 | 108,324 (Direct) |
View |
| 2005-03-31 Other |
2005-04-27 6:20 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 1,133 | $0.595 | $674 | 6,497 (Direct) | View |
| 2004-03-31 Other | 2004-05-25 9:52 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 1,025 | $1.479 | $1,516 | 3,815 (Direct) | View |
| 2003-06-30 Other | 2003-09-19 6:02 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 498 | $1.479 | $737 | 1,825 (Direct) | View |
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2006-04-17 Option Award | 2006-04-18 3:49 pm | N/A 2016-04-17 |
LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 310,430 | $4.46 | 361,027 (Direct) |
View |
| 2005-10-10 Option Award |
2005-10-12 5:22 pm | N/A 2015-10-10 |
LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 143,000 | $0 | 253,000 (Direct) |
View |
| 2005-05-19 Option Award |
2005-05-20 5:17 pm |
N/A 2015-05-19 |
LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 37,235 | $0 | 110,000 (Direct) |
View |
| 2005-04-25 Option Award |
2005-04-27 6:20 pm |
N/A 2015-04-25 | LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 72,765 | $0 | 859,934 (Direct) |
View |
| 2005-04-26 Gift | 2005-04-27 6:20 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 787,169 | $0 | 72,765 (Direct) |
View |
| 2005-04-26 Gift |
2005-04-27 6:20 pm | N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 787,169 | $0 | 787,169 (Indirect) | View |
| 2004-05-21 Option Award |
2004-05-25 9:52 pm | N/A 2014-05-21 |
LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 122,000 | $2.96 | 122,000 (Direct) | View |
| 2003-09-18 Option Award | 2003-09-19 6:02 pm |
N/A 2013-09-18 |
LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 14,662 | $4.71 | 608,662 (Direct) | View |
| 2003-09-18 Option Award |
2003-09-19 6:02 pm | N/A 2013-09-18 |
LA JOLLA PHARMACEUTICAL CO | LJPC | LINNIK MATTHEW D (CSO & Exec VP of Research) | 60,338 | $4.71 | 669,000 (Direct) |
View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Fri, 05 Dec 2008 06:25:13 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |